421924006: Rotigotine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Rotigotine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Rotigotine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Aliphatic amine (substance)\Aralkylamine (substance)\Rotigotine (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Aliphatic amine (substance)\Aralkylamine (substance)\Rotigotine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2615490013 Rotigotine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2618159018 Rotigotine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

53371000195111 rotigotina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

838951000172116 rotigotine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

68241000195111 Rotigotin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rotigotine (substance)	Is a	Aralkylamine (substance)	true	Inferred relationship	Some
Rotigotine (substance)	Is a	Dopamine receptor agonist	true	Inferred relationship	Some
Rotigotine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Rotigotine (substance)	Is a	Antiparkinsonian agent (substance)	true	Inferred relationship	Some
Rotigotine (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing rotigotine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 4mg/24hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rotigotine (substance)	Inferred relationship	Some
Rotigotine 2mg/24hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rotigotine (substance)	Inferred relationship	Some
Rotigotine 6mg/24hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rotigotine (substance)	Inferred relationship	Some
Rotigotine-containing product in transdermal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rotigotine (substance)	Inferred relationship	Some	1
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rotigotine (substance)	Inferred relationship	Some	1
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rotigotine (substance)	Inferred relationship	Some	1
Product containing only rotigotine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rotigotine (substance)	Inferred relationship	Some	1
Product containing only rotigotine in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 125 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 125 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rotigotine (substance)	Inferred relationship	Some	1
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rotigotine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets